Home
Aurobindo Pharma Ltd EPS

Aurobindo Pharma Ltd
NSE: AUROPHARMA
EPS
Key Highlights
- The Earning per Share of Aurobindo Pharma Ltd is ₹ 60.7 as of 21 Feb 25 .
- The earning per share of Aurobindo Pharma Ltd changed from ₹ 9.74 to ₹ 14.56 over 7 quarters. This represents a CAGR of 25.83% .
Historical Earning per Share of Aurobindo Pharma Ltd
EPS, or Earnings Per Share, is a financial metric that represents the portion of a company's profit allocated to each outstanding share of common stock. It indicates a company's profitability and is calculated by dividing net income by the number of outstanding shares.
Historical Earning per Share of Aurobindo Pharma Ltd
Company Fundamentals for Aurobindo Pharma Ltd
Market Cap
65,358 Cr
EPS
60.7
P/E Ratio (TTM)
18.4
P/B Ratio (TTM)
2.1
Day’s High
1125.55
Day’s Low
1097.75
DTE
0.3
ROE
11.6
52 Week High
1592.55
52 Week Low
985.0
ROCE
13.7
Market Price of Aurobindo Pharma Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 1115.45 |
20 Feb 2025 | 1120.85 |
19 Feb 2025 | 1136.3 |
18 Feb 2025 | 1164.05 |
17 Feb 2025 | 1170.05 |
14 Feb 2025 | 1129.8 |
13 Feb 2025 | 1180.05 |
12 Feb 2025 | 1145.2 |
11 Feb 2025 | 1146.8 |
10 Feb 2025 | 1176.8 |
SWOT Analysis Of Aurobindo Pharma Ltd
BlinkX Score for Aurobindo Pharma Ltd
Asset Value vs Market Value of Aurobindo Pharma Ltd
Market Value
₹ 65,359
Asset Value
Value addition
1.6 X
₹ 25,059
* All values are in ₹ crores
Competitive Comparison of EPS
Company | Market Cap | EPS |
---|
Aurobindo Pharma Ltd | 65358 | 60.7 |
Sun Pharmaceuticals Industries Ltd | 394223 | 49.16 |
Divis Laboratories Ltd | 152610 | 77.86 |
Cipla Ltd | 119067 | 61.78 |
Torrent Pharmaceuticals Ltd | 102739 | 55.02 |
Dr Reddys Laboratories Ltd | 96124 | 64.37 |
Company | |
---|---|
Aurobindo Pharma Ltd | 65358 |
Sun Pharmaceuticals Industries Ltd | 394223 |
Divis Laboratories Ltd | 152610 |
Cipla Ltd | 119067 |
Torrent Pharmaceuticals Ltd | 102739 |
Dr Reddys Laboratories Ltd | 96124 |
Historical Market Cap of Aurobindo Pharma Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Aurobindo Pharma Ltd
Historical Revenue of Aurobindo Pharma Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Aurobindo Pharma Ltd
Historical EBITDA of Aurobindo Pharma Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Aurobindo Pharma Ltd
Historical Net Profit of Aurobindo Pharma Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Aurobindo Pharma Ltd
Dividend Payout Over Time
Aurobindo Pharma Ltd News Hub
Aurobindo Pharma tumbles after US FDA issues warning letter to Telangana unit
In May 2024, the United States Food and Drug Administration (US FDA) had conducted an inspection at
Read more
16 Aug 24
Eugia Pharma Specialities receives USFDA warning for Unit III
Aurobindo Pharma announced that the USFDA has issued a warning letter for Unit-III of Eugia Pharma S
Read more
16 Aug 24
Aurobindo Pharma consolidated net profit rises 61.05% in the June 2024 quarter
Net profit of Aurobindo Pharma rose 61.05% to Rs 919.22 crore in the quarter ended June 2024 as agai
Read more
12 Aug 24
Auro Pharma Q3 PAT slides 10% YoY to Rs 846 crore
However, revenue from operations increased 8.53% year on year (YoY) to Rs 7,978.52 crore in the quar
Read more
07 Feb 25